Cognitive deficit in first-time coronary artery bypass graft patients: A randomized clinical trial of lidocaine versus procaine hydrochloride

Perfusion (United Kingdom)

Volumn 27, Issue 4, 2012, Pages 320-325

  Ghafari, R ^a   Baradari, A Gholipour ^a   Firouzian, A ^a   Nouraei, M ^a   Aarabi, M ^b   Zamani, A ^a   Zeydi, A Emami ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CABG; cardioplegic solution; cognitive function; lidocaine; procaine hydrochloride

Indexed keywords

CARDIOPLEGIC AGENT; LIDOCAINE; PROCAINE;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NEUROPROTECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANESTHETICS, LOCAL; CARDIOPLEGIC SOLUTIONS; COGNITION; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIDOCAINE; MALE; MIDDLE AGED; PROCAINE; TIME FACTORS;

EID: 84862905214     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659112446525     Document Type: Article

References (21)

1. Expert Opin Biol Ther. Fleisig AJ Pexelizumab Verrier ED, ed. 2005: 833-839.
2. Wang D, Wu X, Li J, Xiao F, Liu X, Meng M. The effect of lidocaine on early postoperative cognitive dysfunction after coronary artery bypass surgery. Anesth Analg. 2002 ; 95: 1134-1141
3. Newman MF, Kirchner JK, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary artery bypass surgery. N Engl J Med. 2001 ; 344: 395-402
4. Sendelbach S, Lindquist R, Watanuki S, Roman DD, Savik K. Early neurocognitive function of patients after off-pump coronary artery bypass surgery. Heart Lung. 2005 ; 34: 367-374
5. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary artery bypass surgery. N Engl J Med. 1996 ; 335: 1857-1863
6. Brown WR, Moody DM, Challa VR. Cerebral fat embolism from cardiopulmonary bypass. J Neuropathol Exp Neurol. 1999 ; 58: 109-119
7. Roach GW, Newman MF, Murkin JM, et al. Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. Multicenter Study of Perioperative Ischemia (McSPI) Research Group [comment]. Anesthesiology. 1999 ; 90: 1255-1264
8. Levy J, Ramsay J, Murkin J. Aprotinin reduces the incidence of strokes following cardiac surgery. Circulation. 1996 ; 94: I535
9. Legault C, Furberg CD, Wagenknecht LE, et al. Nimodipine neuroprotection in cardiac valve replacement: report to an early terminated trial. Stroke. 1996 ; 27: 593-598
10. Schmitt B, Bauersfeld U, Fanconi S, et al. The effect of the N-methyl-D-aspartate receptor antagonist dextromethorphan on perioperative brain injury in children undergoing cardiac surgery with cardiopulmonary bypass: results of a pilot study. Neuropediatrics. 1997 ; 28: 191-197
11. Mitchell SJ. Lidocaine in the treatment of decompression illness: a review of the literature. Undersea Hyperbaric Med. 2001 ; 28: 165-174
12. Fried E, Amorim P, Chambers G, et al. The importance of sodium for anoxic transmission damage in rat hippocampal slices: mechanisms of protection by lidocaine. J Physiol (Lond). 1995 ; 489: 557-565
13. Sakabe T, Maekawa T, Ishikawa T, Takeshita H. The effects of lidocaine on canine cerebral metabolism and circulation related to the EEG. Anesthesiology. 1974 ; 40: 433-441
14. Taylor CP, Burke SP, Weber ML. Hippocampal slices: glutamate overflow and cellular damage from ischemia are reduced by sodium-channel blockade. J Neurosci Methods. 1995 ; 59: 121-128
15. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993 1993 ; 269 (18). 2386-2391
16. Selnes OA, Goldsborough MA, Borowicz LM, McKhann GM. Neurobehavioural sequelae of cardiopulmonary bypass. Lancet. 1999 ; 353: 1601-1606
17. Sotaniemi KA, Mononen H, Hokkanen TE. Long-term cerebral outcome after open-heart surgery: a five-year neuropsychological follow-up study. Stroke. 1986 ; 17: 410-416
18. Hogue CW, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes: an evidence based appraisal of current practices. Anesth Analg. 2006 ; 103: 21-37
19. Mitchell SJ, Pellett O, Gorman DF. Cerebral protection by lidocaine during cardiac operations. Ann Thorac Surg. 1999 ; 67: 1117-1124
20. Mitchell SJ, Merry AF, Frampton C, et al. Cerebral protection by lidocaine during cardiac operations: a follow-up study. Ann Thorac Surg. 2009 ; 87: 820-825
21. Mathew JP, Mackensen GB, Phillips-Bute B, et al. Randomized, double-blinded, placebo controlled study of neuroprotection with lidocaine in cardiac surgery. Stroke. 2009 ; 40: 880-887